Market By Cgms Component Type, Cgms End-user, Cgms Demographics, Smbg Type, Smbg End-user And Smbg Application | Forecast 2019-2025
Triton's report has determined the continuous glucose monitoring system comprising (CGMS) and self-monitoring of blood glucose (SMBG) market in South Korea to proliferate at a compound annual growth rate of 29.98% and 5.02% respectively, during the forecast period 2019-2025.
The rising incidence of diabetes is propelling the glucose monitoring system market in South Korea. Diabetes leads to illnesses such as stroke, heart disease, blindness, kidney disease and other debilitating diseases. More than 90% of all cases of diabetes are type 2, and gestational diabetes develops in one out of 25 pregnancies worldwide. It is associated with complications to both mother and baby. Also, continuous glucose monitoring has been a significant improvement over blood glucose testing devices that provide glucose readings at intervals. The use of glucose monitoring systems for diabetic patients leads to the stabilization of elevated HbA1C levels, which minimizes the risk of developing long-term diabetic complications. The use of these systems is thereby driving the South Korea glucose monitoring system market.
Although reimbursements are being provided now, they are inadequate owing to the lack of irrefutable evidence with regard to the accuracy of continuous glucose monitoring systems. People living on or below the poverty line tend to be undiagnosed and have a lesser scope of access to treatment, and they agonize more severe and late difficulties than the rich. The majority of poor people and even the middle-class people in developing countries do not have health insurance and are forced to pay for the blood glucose tests which can restrict the growth of glucose monitoring system market in South Korea.
Triton Market Research’s report on the South Korea glucose monitoring system market provides in-depth insight and segmentation analysis of the market. The detailed analysis of the market includes the key buying criteria, PESTEL analysis, value chain analysis, the healthcare system in South Korea and the market attractiveness index. The segmentation analysis of the South Korea glucose monitoring system market includes; market by CGMS component type, by CGMS end-user, by CGMS demographics, by SMBG type, by SMBG end-user and by SMBG application.
The competitive players in the South Korea glucose monitoring system market are Apex Biotechnology Corp, Roche Diagnostics, Johnson & Johnson, B Braun Melsungen AG, Becton Dickinson and Company, I-Sens Inc, Arkray Inc., OSANG Healthcare and Abbott Laboratories.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. SOUTH KOREA GLUCOSE MONITORING SYSTEM MARKET - SUMMARY
1.2.
MARKET DRIVING ASPECTS
1.3.
MARKET RESTRAINING ASPECTS
1.4. KEY PLAYERS
2. SOUTH
KOREA GLUCOSE MONITORING SYSTEM INDUSTRY OUTLOOK
2.1. MARKET
DEFINITION
2.2. PESTEL
ANALYSIS
2.2.1. POLITICAL
2.2.2. ECONOMICAL
2.2.3. SOCIAL
2.2.4. TECHNOLOGICAL
2.2.5. LEGAL
2.2.6. ENVIRONMENTAL
2.3. HEALTHCARE
SYSTEM IN SOUTH KOREA
2.4. DRUGS
AND DEVICES FOR DIABETES TREATMENT
2.5. KEY
BUYING CRITERIA
2.6. VALUE
CHAIN ANALYSIS
2.7. MARKET
ATTRACTIVENESS INDEX
3. SOUTH
KOREA GLUCOSE MONITORING SYSTEM MARKET - SEGMENTATION
3.1. BY CGMS COMPONENT TYPE (SENSORS, TRANSMITTER AND RECEIVERS, INTEGRATED INSULIN PUMPS)
3.2. BY CGMS END USER (HOME SETTINGS, DIAGNOSTICS AND CLINICAL, HOSPITAL)
3.3. BY CGMS DEMOGRAPHICS (ADULT POPULATION (>14YEARS), CHILD POPULATION (>14YEARS))
3.4. BY SMBG TYPE (TEST STRIPS, GLUCOSE METER, LANCETS)
3.5. BY SMBG END USER (HOME SETTINGS, CLINICAL, HOSPITAL)
3.6. BY SMBG APPLICATION (TYPE 1 DIABETES, TYPE 2 DIABETES, GESTATIONAL DIABETES)
4. COMPETITIVE
LANDSCAPE
4.1. ABBOTT
4.2. APEX
BIOTECHNOLOGY CORP.
4.3. ARKRAY,
INC.
4.4. B
BRAUN MELSUNGEN AG
4.5. BECTON
DICKINSON AND COMPANY
4.6. I-SENS,
INC.
4.7. JOHNSON
& JOHNSON
4.8. OSANG
HEALTHCARE
4.9. ROCHE
DIAGNOSTICS
5. RESEARCH
METHODOLOGY & SCOPE
5.1. RESEARCH
SCOPE & DELIVERABLES
5.1.1. OBJECTIVES
OF STUDY
5.1.2. SCOPE
OF STUDY
5.2. SOURCES
OF DATA
5.2.1. PRIMARY
DATA SOURCES
5.2.2. SECONDARY
DATA SOURCES
5.3. RESEARCH
METHODOLOGY
5.3.1. EVALUATION
OF PROPOSED MARKET
5.3.2. IDENTIFICATION
OF DATA SOURCES
5.3.3. ASSESSMENT
OF MARKET DETERMINANTS
5.3.4. DATA
COLLECTION
5.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1 SOUTH KOREA GLUCOSE MONITORING
SYSTEM MARKET 2019-2025 ($ MILLION)
TABLE
2 AVERAGE PRICES OF GLUCOSE TEST
STRIPS, LANCETS AND GLUCOSE METER IN SOUTH KOREA (US $)
TABLE
3 SOUTH KOREA - COUNTRY SNAPSHOT
TABLE
4 SOUTH KOREA GLUCOSE MONITORING
SYSTEM MARKET BY CGMS COMPONENT TYPE 2019-2025 ($ MILLION)
TABLE
5 SOUTH KOREA GLUCOSE MONITORING
SYSTEM MARKET BY CGMS END-USER 2019-2025 ($ MILLION)
TABLE
6 SOUTH KOREA GLUCOSE MONITORING
SYSTEM MARKET BY CGMS DEMOGRAPHICS 2019-2025 ($ MILLION)
TABLE
7 SOUTH KOREA GLUCOSE MONITORING
SYSTEM MARKET BY SMBG TYPE 2019-2025 ($ MILLION)
TABLE
8 SOUTH KOREA GLUCOSE MONITORING
SYSTEM MARKET BY SMBG END-USER 2019-2025 ($ MILLION)
TABLE
9 SOUTH KOREA GLUCOSE MONITORING
SYSTEM MARKET BY SMBG APPLICATION 2019-2025 ($ MILLION)
FIGURE
1 SOUTH KOREA GLUCOSE MONITORING
SYSTEM MARKET 2019-2025 ($ MILLION)
FIGURE
2 SOUTH KOREA SMBG SALES CHANNEL
2019-2025 ($ MILLION)
FIGURE
3 VALUE CHAIN ANALYSIS OF CGMS MARKET
FIGURE
4 MARKET ATTRACTIVENESS INDEX